Venus Remedies Q1 net profit records 629.5 per cent increase
Propelled by robust sales, the company’s net profit increased to Rs 14.59 crores in the first quarter of FY 2021-22 from Rs 2…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Venus Remedies
Venus Remedies forays into consumer healthcare, launches R3SET for pain management
To introduce products covering key segments like pain management, gastro-enterology, hygiene, stress management, vitamins, and…
Venus Remedies wins battle against SCR Pharmatop to revoke Indian patent for IV paracetamol
Venus Remedies challenged the Indian patent by the French pharmaceutical giant SCR Pharmatop in 2011 after prompted by an…
West Pharma, Venus Remedies partner to launch NovaGuard SA Pro Safety System in India
NovaGuard SA Pro safety system helps biopharma manufacturers package drugs in a prefillable syringe with a needle stick injury…
Cipla acquires anti-infective product Elores from Venus Remedies
The acquisition is aimed at further strengthening the firm's presence in branded Indian critical care space, and as a part of its…
Venus gets marketing authorisation for Meropenem
Meropenem is a last-resort drug of the carbapenem class of antibiotics which is used in intensive care units (ICUs) of hospitals